IL-13 R130Q single nucleotide polymorphism in asthmatic Egyptian children by El-Sayed, Zeinab A et al.
Egypt J Pediatr Allergy Immunol 2010;8(1):9-18. 
9 
 




Asthma and its associated intermediate phenotypes 
are under a substantial degree of genetic control. 
Identifying the genes underlying asthma offers a 
mean of better understanding its pathogenesis1.  The 
importance of genetic factors in influencing the risk 
of developing allergic inflammation is well 
established2. Linkage association studies and 
genome-wide screening suggest that multiple genes 
are involved in the pathogenesis of asthma. 
However, many segregation studies suggest that a 
major gene could be involved in asthma, but until 
now different genetic models have been obtained3. 
IL-13 is an immunoregulatory cytokine 
produced primarily by activated Th2 cells, mast 
cells and natural killer cells (NK) cells. IL-13 is a 
17-kD glycoprotein4. The gene encoding IL-13 is 
located only 25 kilobases upstream of the gene for 
IL-4 and in the same orientation, leading to the 
speculation that these genes arose as a duplication 
event during evolution. In addition to their 
structural similarities they share considerable 
functional similarities. They are both known to 
have a number of actions relevant to the asthmatic 
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diathesis such as the regulation of isotype class 
switching in B cells to IgE synthesis, induction of 
the expression of MHC II and CD23, the induction 
of adhesion molecule expression on endothelial 
cells e.g. vascular cell adhesion molecule-1 
(VCAM-1), chemokine production (eotaxin), the 
activation of mast cells and eosinophils, and the 
inhibition of proinflammatory gene expression (IL-
1, TNF and IL-6). This overlap in function is due to 
the sharing of a receptor chain in their individual 
multimeric receptor complexes IL-4R5. 
The central role of IL-13 in asthma and allergy 
is also highlighted by studies that demonstrated that 
the biologic effects of IL-9 and IL-25 are mediated 
via IL-13, and that histamine can induce IL-13 
production in some experimental circumstances6. 
IL-13 induces airway hyperreactivity (AHR) as 
it is known to regulate the production of a number 
of secreted molecules that alter the contraction or 
relaxation of airway smooth muscle cells and it 
inhibits the activity of inducible nitric oxide 
synthase, which would result in a decrease in 
production of the bronchodilator nitric oxide7. 
Genetic polymorphism arises from mutation. 
Different classes of polymorphism are generally 
named on the basis of the type of mutation from 
which they result. The simplest class of 
polymorphism derives from a single base mutation 
that substitutes one nucleotide for another. Such 
polymorphism has been called a single nucleotide 
polymorphism, or SNP.  
Common single-nucleotide polymorphisms in 
IL-13 are associated with allergic phenotypes in 
several ethnically diverse populations. In particular, 
IL13+2044G→A is expected to result in the 
nonconservative replacement of arginine 130 
(R130) with glutamine (Q)8. The impact of 
IL13+2044G→A on the functional properties of IL-
13 was examined by comparing the activity of wild 
type (WT) IL-13 and IL-13 R130Q on primary 
human cells involved in the effector mechanisms of 
allergic inflammation. Notably, IL-13 R130Q was 
neutralized less effectively than WT IL-13 by an 
IL-13Rα2 decoy. Decreased neutralization of the 
minor variant could contribute to its enhanced in 
vivo activity. Neither of the IL-13 variants was able 
to engage T cells, which suggests that increased 
allergic inflammation in carriers of IL13+2044A 
depends on enhanced IL-13–mediated Th2 effector 
functions rather than increased Th2 differentiation. 
Collectively, data indicate that natural variation in 
the coding region of IL-13 may be an important 
genetic determinant of susceptibility to allergy9. 
IL-13 R130Q is more active than WT IL-13 in 
up regulating CD23 expression in primary 
monocytes10. IL-13 R130Q is more active than WT 
IL-13 in inducing hydrocortisone-dependent, but 
not CD40-dependent, IgE synthesis. Together with 
IL-4, IL-13 is the only cytokine which has been 
shown to induce IgE class switching. This effect 
requires synergistic interactions with a second 
signal typically provided by CD40 engagement11. 
With this as a background, we were stimulated 
to study the association of the IL-13 variant R130Q 
with childhood bronchial asthma and its relation to 





This case-control pilot study comprised 20 
asthmatic and 20 healthy children as a stratified 
non-randomized sample. The asthmatic children 
were enrolled consecutively from the Pediatric 
Allergy and Immunology Unit, Children's Hospital, 
Ain Shams University, Cairo, Egypt. The diagnosis 
of asthma in the studied patients was made 
according to the criteria of the American Thoracic 
Society12. They were 10 males and 10 females. 
Their ages ranged from 5 to 13 years with a mean 
age of 8.75±2.88 years. Their duration of illness 
ranged from 1 year to 12 years, with a mean of 6.43 
±2.78 years. According to the GINA13 
classification, the selected patients were classified 
into 7 patients with severe persistent asthma and 13 
patients with moderate persistent asthma. The 
patients were studied during acute asthma 
exacerbation, and graded into 7 with mild, 7 with 
moderate and 6 with severe exacerbation. Weight 
and height measurements were recorded and plotted 
against the normal percentiles for age14. Children 
with data suggestive of chest infection, parasitic or 
concomitant diseases were excluded from the study. 
The control group comprised 20 clinically healthy 
children (10 males and 10 females).  Their ages 
ranged from 5 to 13 years with a mean value of 
8.55±2.84 years.  They had no personal or family 
history of atopy. 
An informed consent was obtained from the 
parents or care-givers of all children before 
enrollment. The study protocol was approved by the 
ethics committee of the Department of Pediatrics, 
Ain Shams University. 
 
Study Measurements 
Blood sample collection and processing 
Six ml venous blood sample was drawn aseptically 
from every subject in vacutainer cell preparation 
tube (CPT) with sodium citrate for blood cell 
counting, total IgE assay and detection of IL-13 
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gene polymorphism R130Q. The tube was stored 
upright at room temperature and centrifuged within 
two hours at 2760 rpm for 20 minutes at 22 ْC. The 
whitish mononuclear cell layer was collected with a 
Pasteur pipette and transferred to 25 ml size conical 
centrifuge tube. Washing with PBS with 
centrifugation at 560 rpm for 15 minutes and 
discarding of the supernatant was done twice then 
the cell pellet was resuspended and subsequently 
used for DNA extraction. 
 
Detection of IL-13 gene polymorphism (R130Q) 
DNA extraction from mononuclear cells using 
(Purescript total DNA Isolation kit, Gentra, Cat. 
No.5500A, USA) in accordance with the 
manufacturer’s instructions, then DNA was 
amplified using standard procedures15. The primer 




amplification was carried out in 20 μL containing 
0.1 μM of each primer, 1.5 mM MgCl2, 200 μM 
dNTPs, 50 ng of DNA template, 1 U of Taq DNA 
polymerase, and 1X PCR buffer in a Gene Amp 
PCR system (PerkinElmer 9600 Thermocycler, 
Waltham, Massachusetts, USA).  
Amplification products were double strands 
sequenced using (ALF express autoread sequencing 
kit, Amersham pharmacia biotech, USA). DNA 
sequence analysis of the amplified products was 
done in four steps namely denaturation reaction, 
annealing reaction, labeling reaction and terminal 
reaction. Then 8μL of each sequencing  reaction 
product were loaded into wells of sequencing gel, 
this was followed by electrophoresis of the gel, 
exposing and developing the film then the DNA 
sequence was read from the film using ALF express 
sequencer and the resultant chromatogram was 
analyzed by consed 30 software, and a blast at 
(http:www.ncbi.nucleotide.gov) search.  
 
Serum total IgE 
Serum total IgE was measured by ELISA technique 
(Genzyme Diagnostics, Medix Biotech, San Carlos, 
Calif). The value of IgE used for data analysis was 
calculated as a percentage of the highest normal for 
age16. 
 
Complete blood counting 
Complete blood counting (CBC) was done using 
Coulter Counter (Coulter Microdiff 18, Fullerton, 
CA, USA) and the differential counts were carried 
out manually. Blood sampling of all subjects was 
performed at the same time daily (10 am) to avoid 
diurnal variations in eosinophil counts. The normal 
value of absolute eosinophilic count for age group 
5-13 is 0.1- 1 x103/μl. 
 
Statistical analysis 
Data were analyzed by computer using the 
statistical program SPSS for Windows version 13. 
The mean, SD, median and IQ range were presented 
for the descriptive analysis of the groups. Groups 
were compared using the Student's t-test or the 
Mann-Whitney test (in case of non-parametric 
data). Fisher's Exact test was used for comparison 
of categorical data. In all tests p values less than 
0.05 were considered statistically significant. 
 
RESULTS 
In our study, 50% of the asthmatic children had 
the common variant of IL-13, IL-13R130Q (GA), 
while the other 50% had the wild type (WT) IL-13 
(GG). On the other hand only 3/10 (15%) of the 
healthy controls were positive for IL-13R130Q, and 
the remainder were presenting the wild GG 
genotype (fig. 1). The difference between the 
frequencies of patients and controls was statistically 
significant. 
Comparison of serum total IgE levels as percent 
of normal for age in asthmatic children with GA 
and GG genotypes revealed that the levels were 
significantly higher in patients with GA compared 
to those with GG genotype with a mean of 373.25 ± 
238.11% and 44.28 ± 42.65% respectively. Also the 
frequency of elevated total IgE was 90% in patients 
with the GA genotype compared to only 10% in 
those with the GG genotype (p<0.001). Control 
children with GA genotype also had significantly 
higher serum total IgE as percent of normal for age 
(mean of 28.03 ± 9.12%) as compared to those with 
GG genotype (mean of 11.70 ± 5.00%). 
The AEC, as percent of normal, was slightly 
higher in GA patients compared to GG patients 
(mean values: 94.50 ± 83.80 and 67.20 ± 1.46 
respectively p>0.05). However the respective 
values in controls were significantly different 
[mean values 250.00 ± 51.96 and 52.94 ± 36.87 
respectively]. The frequency of elevated AEC was 
higher in GA patients compared to those with GG 
genotype (40% versus 10% respectively). On the 
other hand, all GA controls had an elevated AEC 
above normal in comparison to 17.64% only in 
controls with the GG genotype. 
The present study failed to demonstrate a 
relation of the genetic profile of IL-13 to history of 
upper respiratory tract infections or food allergy as 
triggering factors for bronchial asthma 
exacerbations. 
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The impact of the presence of polymorphism of 
the gene of IL-13 on the severity of asthma was 
explored. No significant differences were observed 
between asthmatic patients harboring the gene 
polymorphism R130Q (GA) and those with the wild 
type (GG genotype) as regards the grading of 
asthma or the severity of the acute exacerbation. In 
this context, 60% of GA genotype harborors had 
moderate persistent asthma and 40% had severe 
persistent asthma in comparison to 70% and 30% 





























Figure 1. Interleukin 13 gene polymorphism 





Table 1. Demographic differences among  




















Males 6 (60%) 4 (40%) 























+ve  7 (70%) 7 (70%) 
- ve  3 (30%) 3 (30%) 
URTI 
+ve 4 (40%) 7 (70%) 
-ve 6 (60%) 3 (30%) 
History of food allergy 
+ve 4 (40%) 6 (60%) 










FH: family history; GA: IL- I3R130Q; GG: normal IL-13, Ht= 
height; n=number, ns= non significant, s= significant; t=t value 
of student-t test, URTI: upper respiratory tract infection. ht= 












n=9 (90%)  
Figure 2. Distribution of asthmatic children with high IgE level. 
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z = 3.48 
Figure 3. Serum total IgE as percent of normal for age of asthmatic patients with GA and GG genotypes. 
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z = 1.66                     p > 0.05 
Figure 5. Distribution of asthmatic children with high absolute eosinophilic count (AEC). level. 
 
 
z = 1.66 
Figure 6. Absolute eosinophilic count as percent of normal for age of GA and GG patients. 
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DISCUSSION 
Polymorphisms that may dysregulate the function 
and/or the expression of IL-13 occur frequently in 
the population and have been consistently 
associated with allergic phenotypes17.  Arima and 
associates18 have recently provided evidence that 
the Arg110Gln may be a functional variant. 
Utilizing a mutant recombinant IL-13, they showed 
that recombinant IL-13 containing the Gln110 
variant bound the IL-13 receptor α2 chain with 
lower affinity than the wild-type IL-13, resulting in 
a lower clearance rate of the cytokine. Furthermore 
the asthmatic patients homozygous for the Gln110 
variant had higher serum levels of IL-13 than those 
without the variant. They postulated that impaired 
binding of IL-13 by the soluble IL-13Rα2 chain 
leads to higher serum levels and prolonged activity 
of IL-13 in vivo. 
The present study revealed a significantly more 
frequent occurrence of the IL-13 polymorphism 
R130Q (GA) in asthmatic children than in healthy 
controls (50% versus15% respectively). This 
indicates that natural variation of the coding region 
of  IL-13 may be an important genetic determinant 
of the susceptibility to asthma, based on the fact 
that IL-13R130Q is significantly more active than 
WT IL-13 in enhancing essential effector pathways 
of allergic inflammation in primary human cells10.  
This can be simply explained by the hypothesis that 
R130 is important for IL-13 binding to IL-13 Rα2 
which is a key negative regulator of IL-13 
responses in vivo. Hence, this IL-13 variant might 
to some extent escape the damping mechanisms that 
normally restrain the activity of WT IL-13 in vivo. 
This comes in accordance with a case- control 
study on British and Japanese panels8 in which it 
was found that IL-13 R130Q was significantly more 
common among asthmatics than controls in both 
populations and that this IL-13 variant seemed to 
have longer plasma half- life. In addition, Homšak 
et al19 suggested that IL-13 polymorphism R130Q 
is highly connected with both types of asthma 
atopic and non atopic. However, other researchers20 
found a weak evidence of association between IL-
13R130Q allele and increased risk of atopy and 
atopic dermatitis, most strongly in white children.  
Chen and associates21 indicated that SNP in IL-
13 namely R130Q resulted in a significant 
biological difference as evidenced by the fact that 
R130Q induced airway hyperresponsiveness with 
doses of  recombinant IL-13 R130Q significantly 
lower than that of the WT IL-13.  
In contrast, other studies suggested that the 
R130Q polymorphism of IL-13 gene was not 
associated with asthma in Chinese children and it 
did not correlate with subjective or objective 
indicators of asthma severity22. Also they found that 
R130Q did not increase in frequency with airway 
hyperresponsiveness, asthma diagnosis or severity 
but was correlated with overall allergy phenotype, 
rather than an isolated association with one specific 
component of allergy such as elevated serum 
IgE22,23. Moreover, no association or linkage of the 
R130Q variant and lung functions in COPD patients 
was found in  some studies; a finding which was 
explained by the hypothesis that IL-13 may only 
contribute to COPD in those individuals who have a 
concurrent asthma and/or airway hyper-
responsiveness24. As obvious from these data, the 
results of studies on the polymorphism of IL-13 
gene vary widely especially from a population to 
another: IL-13R130Q SNPs being prominent 
among British, Japanese as well as Egyptian 
asthmatics whereas this was not the case with the 
Chinese.  
Previous reports have shown that genetic 
variants of the IL-13 promoter and coding regions 
were involved in the pathogenesis of asthma25,26. 
Hence, the impact of IL13 R130Q polymorphism 
on IgE levels was explored. Comparison of serum 
total IgE as percent of normal for age in asthmatic 
children with GA and GG genotypes revealed that 
IgE% was significantly higher in patients with the 
GA genotype with a mean of 373.25% and 44.28% 
respectively. Also the total IgE was elevated in 90% 
of patients with GA genotype compared to only 
10% in those with GG genotype. This finding can 
be explained by the ability of IL-13R130Q to over 
express CD23 which contributes to the increase in 
the IgE- dependant inflammation10. 
The IgE levels as percent of normal for age was 
significantly higher in our asthmatic patients than in 
healthy controls with a mean of 208.77% and 
14.21% respectively. IgE molecules play a crucial 
role in allergic respiratory diseases and may cause 
chronic airway inflammation in asthma through 
activation of effector cells via high affinity FcЄRI 
or low affinity FcЄRII IgE receptors27. Allergen-
specific IgE synthesized in response to allergens in 
the environment becomes fixed to FcЄRI on the 
membranes of mast cells and basophils. 
Aggregation of receptor bound IgE molecules on 
re-exposure to specific allergen results in the 
production of mediators that produce the allergic 
response28. 
Strange enough, control children with GA 
genotype also had significantly higher serum total 
IgE as percent of normal for age as compared to 
those with GG genotype. This occurred in spite of 
the fact that both subgroups had within normal 
El-Sayed et al. 
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values of IgE. This may reflect a susceptibility to 
later develop an atopic phenotype among at-present 
clinically normal children. Several studies found 
that R130Q polymorphism of IL-13 gene is 
associated with elevated serum total and allergen-
specific IgE and stated that this variant is useful in 
the detection of subjects at risk of having elevated 
serum IgE or atopy22,23. On the contrary, Homšak 
and associates19 found no association or linkage of 
the R130Q variant to IgE level.  
Zitnik et al29 analyzed the effect of two 
functional IL-13 variants (R130Q and c.1-1111 
C>T) in a large population of white children with 
atopic dermatitis and a positive family history of 
asthma and found that IL-13 R130Q variant showed 
statistically significant effects on total serum IgE 
levels with highest values in homozygous subjects 
up to the age of four years. Allele frequencies for 
both IL-13 variants were similar to previous reports 
in white populations30. 
Previously believed to have an exclusive role in 
the release of cytotoxic mediators in the defense 
against helminthic infections, eosinophils are now 
considered key players in inflammatory reaction 
and regulation of immune response. Through 
activation of a large variety of membrane receptors 
and production of various pharmacologically active 
mediators, eosinophils may exert detrimental role in 
tissues in which they have been recruited31. 
Hypereosinophilia in the blood and tissues is one of 
the main characteristics of the pathophysiology of 
allergic diseases. Recent human experiments 
indicated that eosinophils may control the bronchial 
remodeling that occurs in asthma. Furthermore, 
eosinophils are a rich source of fibrogenic factors, 
particularly TGF-B32.  
Whether or not the studied polymorphism 
affects the AEC was subject to exploration. At first, 
the AEC of asthmatic and normal children were 
found comparable; a result that  could be attributed 
to corticosteroids’ intake by asthmatic patients 
causing a reduction in their AEC. A search for 
heterogeneity of AEC between the GA and GG 
genotypes revealed that although the former was 
associated with higher AEC, yet the difference 
among the two groups was statistically 
insignificant. This was not the case with the control 
group where the GA genotype was associated with 
significantly higher mean AEC with 100% of GA 
controls exhibiting high AEC compared to 17.64% 
only in controls with the GG genotype. Demo et al23 
found that R130Q was correlated with the overall 
allergy (combining eosinophil count and total 
serum IgE) as well as with eosinophil count alone. 
Indeed, IL-13 has a major role in allergic 
inflammation through regulation of recruitment and 
activation of inflammatory cells. It has several 
actions relevant to recruitment of T cells and 
eosinophils into the lung. Among these actions are 
its role in up- regulation of vascular cell adhesion 
molecule 1 expression, its ability to prolong 
eosinophil survival, and its activity as an eosinophil 
activation and chemotactic agent. IL-13-induced 
eosinophilia is dependent on IL-5 and eotaxin, 
suggesting that IL-13 induces the production of 
these two eosinophil-active mediators33.   
Environmental triggers of asthma 
exacerbations, namely, upper respiratory tract 
infections and food allergy proved to be irrelevant 
to the genotype of IL-13, a finding which can be 
attributed to the small number of the patients 
examined. However it might indicate that the 
aberrant response of asthmatic individuals to 
environmental triggers such as infections and food 
allergens, is perhaps dictated by genetic 
polymorphism other than that of IL-13. Wider scale 
studies will help decide the exact nature of this 
relationship. Leung and associates22 suggested that 
R130Q is linked to serum concentrations of specific 
IgE to dogs and cockroaches. Zitnik et al29 reported 
a strong association between IL-13 SNPs R130Q 
and c.1-1111 C>T and food allergens particularly 
hen’s egg . 
The studied polymorphism of the gene of IL-13 
had no impact on the severity of asthma or the 
severity of the acute exacerbations. This finding 
was supported by DeMeo et al23 who also found no 
correlation between IL-13R130Q and asthma 
severity. Mijin Kang et al33 reported that the 
+2044G/A polymorphism located in the coding 
region of IL-13 gene was associated with high total 
IgE and maximum percent fall in FEV1 (%) in 
children with asthma and exercise induced 
hyperresponsiveness suggesting that IL-13 
polymorphism may modulate the severity of 
exercise induced hyperresponsiveness in Korean 
children with asthma. 
The results of the present study provide 
preliminary evidence for the association of the 
common variant IL-13 gene polymorphism namely 
IL-13R130Q with the development of pediatric 
asthma. This variant is more active than the wild 
type IL-13 in inducing allergic inflammation as 
reflected by the higher serum total IgE and to some 
extent, AEC. IL-13R130Q might be an important 
genetic determinant of susceptibility to asthma in 
clinically normal children as it is associated with 
higher total IgE and AEC. The decision concerning 
IL-13 R130Q Polymorphism and asthma 
 17
its legibility for future gene therapy targeted at 
reducing its ill- effects awaits larger scale studies. 
In view of the varying results of genetic studies 
among different populations in different locations 
of the world, it becomes a necessity to establish the 
exact genetic profile unique for each population of 
asthmatic children. This will help direct future 
research in the field of gene therapy of asthma to 
suit each genotype. 
 
REFERENCES 
1. Cookson WO. Asthma genetics. Chest 2002; 121(3 
Suppl):7-13. 
2. Bousquet J, Chanez P, Lacoste JY, Barnéon 
G, Ghavanian N, Enander I, et al. Eosinophilic 
inflammation in asthma. N Engl J Med 1990; 
323(15): 1033-9. 
3. Los H, Koppelman GH, Postma DS. The 
importance of genetic influences in asthma. Eur 
Respir J 1999; 14 (5): 1210-27. 
4. Wills-Karp M, Chiaramonte M. Interleukin-13 in 
asthma. Curr Opin Pulm Med 2003; 9(1):21–7. 
5. Howard TD, Koppelman GH, Xu J, Zheng SL, 
Postma DS, Meyers DA, et al. Gene-gene 
interaction in asthma: IL4RA and IL13 in a Dutch 
population with asthma. Am J Hum Genet 2002; 
70:230–6. 
6. Temann UA, Ray P, Flavell RA. Pulmonary 
overexpression of IL-9 induces Th2 cytokine 
expression, leading to immune pathology. J Clin Invest 
2002; 109(1):29–39. 
7. Kuperman DA, Huang X, Koth LL, Chang GH, 
Dolganov GM, Zhu Z, et al. Direct effects of 
interleukin-13 on epithelial cells cause airway 
hyperreactivity and mucus over production in 
asthma. Nat Med 2002; 8(8):885-9. 
8. Heinzmann A, Mao XQ, Akaiwa M, Kreomer RT, 
Gao PS, Ohshima K, et al. Genetic variants of 
IL13 signalling and human asthma and atopy. Hum 
Mol Genet 2000; 9(4): 549-59. 
9. Vladich DF, Brazille SM, Stern D, Peck ML, 
Ghittoni R and Vercelli D. IL-13 R130Q, a 
common variant associated with allergy and asthma, 
enhances effector mechanisms essential for human 
allergic inflammation. J Clin Invest 2005; 115(3): 
747–54. 
10. Gould HJ, Sutton BJ, Beavil AJ, Beavil RL, 
McCloskey N, Coker HA , et al. The biology of 
IgE and the basis of allergic diseases. Annu Rev 
Immunol 2003; 21:579–628. 
11. Jabara HH, Brodeur SR, Geha RS. 
Glucocorticoids upregulate CD40 ligand expression 
and induce CD40L-dependent immunoglobulin 
isotype switching. J Clin Invest 2001; 107(3):371–8. 
12. American Thoracic Society. Medical Section of the 
American Lung Association.  Guidelines for the 
evaluation of impairment / disability in patients with 
asthma.  Am Rev Resp Dis 1993; 147(4): 1056-61. 
13. GINA: Global Strategy for Asthma Management 
and Prevention issued January, 1995, and revised 
2005. NIH Publication No. 02-3659. 
14. Needlman RD. Growth and development.  In: 
Behrman RE, Kliegman RM, Jenson HB, editors. 
Nelson textbook of pediatrics. 17th ed. Philadelphia: 
WB Saunders; 2004. p. 23-66. 
15. Howard TD, Whittaker PA, Zaiman AL, 
Koppelman GH, Xu J, Hanley MT, et al. 
Identification and association of polymorphisms in the 
Interleukin-13 gene with asthma and atopy in a Dutch 
Population. Am J Respir Cell Mol Biol 2001; 25(3): 
377-84. 
16. Sly M. Allergic disorders.  In: Behrman RE, Kliegman 
RM, Jenson HB, editors, Nelson textbook of pediatrics. 
17th ed. Philadelphia: WB Saunders. 2004. p. 743-92. 
17. Hoffjan S, Nicolae D, Ober C. Association 
studies for asthma and atopic diseases: a 
comprehensive review of the literature. Respir Res 
2003;4:14 . 
18. Arima K, Umeshita-SuyamaR, Sakata Y, Akaiwa 
M, Mao XQ, Enomoto T, et al. Upregulation of 
IL-13 concentration in vivo by the IL13 variant 
associated with bronchial asthma. J Allergy Clin 
Immunol 2002; 109(6):980–7. 
19. Homšak M, Zagradišnik B, Vokac NK, Roškar Z, 
Kavalar MS, Bruncko A, et al. IL13 
polymorphism R130Q and total serum IgE levels in 
children with asthma. Eur Respir J 2002; 20(38): 
524-8. 
20. He JQ, Chan-Yeung M, Becker AB, Dimich-ward 
H, Ferguson AC, Manfreda J, et al. Genetic 
variants of the IL13 and IL4 genes and atopic 
diseases in at-risk children. Genes Immun 2003; 
4(5):385–9. 
21. Chen W, Ericksen MB, Levin LS, Khurana 
Hershey GK. Functional effect of the R110Q IL13 
genetic variant alone and in combination with 
IL4RA genetic variants. J Allergy Clin Immunol 
2004;114(3):553-60. 
22. Leung TF, Tang NL, Chan IH, Li AM, Ha G, Lam 
CW. A polymorphism in the coding region of 
interleukin-13 gene is associated with atopy but not 
asthma in Chinese children. Clin Exp Allergy 2001; 
31(10):1515-21. 
El-Sayed et al. 
 18
23. DeMeo DL, Lange C, Silverman EK, Senter JM, 
Drazen JM Barth MJ, et al. Univariate and 
multivariate family based association analysis of the 
IL-13 ARG130GLN polymorphism in the childhood 
asthma management program. Genet Epidemiol 
2002; 23(4):335–48. 
24. He JQ, Connett JE, Anthonisen NR, Sandford 
AJ.  Polymorphisms in the IL13, IL13RA1, and 
IL4RA genes and rate of decline in lung function in 
Smokers.  Am J Respir Cell Mol Biol 2003; 28(3): 
379-85. 
25. Graves PE, Kabesch M, Halonen M, Holberg 
CJ, Baldini M, Fritzsch C, et al. A cluster of 
seven tightly linked polymorphisms in the IL-13 
gene is associated with total serum IgE levels in 
three populations of white children.  J Allergy Clin 
Immunol 2000;105(3):506-13. 
26. Kim HB, Lee YC, Lee SY, Jung J, Jin HS, Kim 
JH, et al. Gene- gene interaction between IL-13 
and IL-13Rα1 is associated with total IgE in Korean 
children with atopic asthma. J Hum Genet 2006; 
51:1055-62. 
27. D'Amato G. Role of anti-IgE monoclonal antibody 
(omalizumab) in the treatment of bronchial asthma 





















28. Prussin C, Metcalfe DD. IgE, mast cells, 
basophils, and Eosinophils. J Allergy Clin Immunol 
2006; 117(2 Suppl Mini-Primer):S450-6. 
29. Zitnik SE, Rüschendrof F, Müller S, Sengler 
C, Lee Y-A, Griffioen RW et al. IL13 variants are 
associated with total serum IgE and early 
sensitization to food allergens in  children with 
atopic dermatitis. Pediatr Allergy Immunol 
2009;20(6):551-5.  
30. Kabesch M, Schedel M, Carr D, Woitsch B, 
Fritzsch C, Weiland SK, et al. IL-4/IL-13 
pathway genetics strongly influence serum IgE 
levels and childhood asthma. J Allergy Clin 
Immunol 2006;117:269-74. 
31. Staumont-Sallé D, Dombrowicz D, Capron M, 
Delaporte E. Eosinophils and urticaria. Clin Rev 
Allergy Immunol 2006; 30(1):13-8. 
32. Garcia G. Allergy-related hypereosinophilia. Presse 
Med 2006; 35:135-43. [Abstr]. 
33. Kang MJ, Lee SY, Kim HB, Yu J, Kim BJ, Choi 
WA, et al. Association of IL-13 polymorphism with 
leukotriene receptor antagonist drug responsiveness 
in Korean children with exercise- induced 
bronchoconstriction. Pharmacogenet Genomics 
2008;18(7):551-8. 
